Nicotinamide Ameliorates Disease Phenotypes in a Human iPSC Model of Age-Related Macular Degeneration
Open Access
- 26 January 2017
- journal article
- research article
- Published by Elsevier BV in Cell Stem Cell
- Vol. 20 (5), 635-647.e7
- https://doi.org/10.1016/j.stem.2016.12.015
Abstract
No abstract availableKeywords
Funding Information
- NIH/NIA (RF1AG042932)
- NIH/NEI (R01EY022079)
- Regenerative Research Foundation
- Empire State Stem Cell Fund
- New York State Department of Health (C028504)
- NIH/NEI (F32EY025931)
This publication has 51 references indexed in Scilit:
- Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in MiceCell Metabolism, 2016
- Human Retinal Pigment Epithelium Stem Cell (RPESC)Advances in Experimental Medicine and Biology, 2015
- Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevityNature, 2014
- Recent developments in the treatment of age-related macular degenerationJCI Insight, 2014
- Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell linesHuman Molecular Genetics, 2014
- Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networksGenome Medicine, 2012
- Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid2011
- Forecasting Age-Related Macular Degeneration Through the Year 2050JAMA Ophthalmology, 2009
- The C. elegans TGF-β Dauer Pathway Regulates Longevity via Insulin SignalingCurrent Biology, 2007
- Human Retinal Pigment Epithelium Cell Changes and Expression of αB-CrystallinAmerican Journal of Ophthalmology, 2007